What Health Canada’s New Special Access Program Amendments Mean For Medical Access To Psychedelics Dec 23, 2021
After 283 Days, Health Minister (Finally) Grants Psilocybin Exemptions To Three Canadians With Mental Health Conditions Dec 14, 2021
COMPASS Pathways announces positive outcome of 25mg COMP360 psilocybin therapy as adjunct to SSRI antidepressants in… Dec 13, 2021
Novamind Opens New Clinic Focused On Substance Use Disorders, Offering Alternative To Residential Treatment Dec 6, 2021
